These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 1874564

  • 1. Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice.
    Törnell J, Rymo L, Isaksson OG.
    Int J Cancer; 1991 Aug 19; 49(1):114-7. PubMed ID: 1874564
    [Abstract] [Full Text] [Related]

  • 2. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice.
    Törnell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L, Isaksson O.
    J Steroid Biochem Mol Biol; 1992 Sep 19; 43(1-3):237-42. PubMed ID: 1525063
    [Abstract] [Full Text] [Related]

  • 3. A mammary-specific promoter directs expression of growth hormone not only to the mammary gland, but also to Bergman glia cells in transgenic mice.
    Günzburg WH, Salmons B, Zimmermann B, Müller M, Erfle V, Brem G.
    Mol Endocrinol; 1991 Jan 19; 5(1):123-33. PubMed ID: 2017187
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The study on transgenic mice.
    Shi YX, Ji XD, Li GS, Shu YM.
    Chin J Biotechnol; 1990 Jan 19; 6(3):189-97. PubMed ID: 2104209
    [Abstract] [Full Text] [Related]

  • 8. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
    Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Törnell J.
    J Clin Invest; 1997 Dec 01; 100(11):2744-51. PubMed ID: 9389738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of human or bovine growth hormone gene with a mouse metallothionein-1 promoter in transgenic swine alters the secretion of porcine growth hormone and insulin-like growth factor-I.
    Miller KF, Bolt DJ, Pursel VG, Hammer RE, Pinkert CA, Palmiter RD, Brinster RL.
    J Endocrinol; 1989 Mar 01; 120(3):481-8. PubMed ID: 2926315
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pituitary morphology of transgenic mice expressing bovine growth hormone.
    Stefaneanu L, Kovacs K, Bartke A, Mayerhofer A, Wagner TE.
    Lab Invest; 1993 May 01; 68(5):584-91. PubMed ID: 8388524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.
    Stewart TA, Pattengale PK, Leder P.
    Cell; 1984 Oct 01; 38(3):627-37. PubMed ID: 6488314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
    Witty JP, Lempka T, Coffey RJ, Matrisian LM.
    Cancer Res; 1995 Apr 01; 55(7):1401-6. PubMed ID: 7882342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice.
    Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS.
    Endocrinology; 1993 Jun 01; 132(6):2518-24. PubMed ID: 8504754
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.